<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The aim of the study was to screen the <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">malignancy</z:e> in an acromegalic patient group and to determine whether there was any increased risk and the incidence of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">malignancy</z:e> and its association with disease characteristics such as duration of disease, latency in diagnosis, and GH and IGF-1 levels </plain></SENT>
<SENT sid="1" pm="."><plain>One hundred-five (65 female, 40 male) patients with <z:hpo ids='HP_0000845'>acromegaly</z:hpo> followed and treated at Cerrahpasa Medical School, Endocrinology and Metabolism outpatient clinic between 1983 and 2007 were included in this study </plain></SENT>
<SENT sid="2" pm="."><plain>The patients were screened with colonoscopy, mammography, and thyroid and prostate ultrasonography (US) </plain></SENT>
<SENT sid="3" pm="."><plain><z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">Malignancy</z:e> was detected in 16 (15%) patients </plain></SENT>
<SENT sid="4" pm="."><plain><z:e sem="disease" ids="C0007115" disease_type="Neoplastic Process" abbrv="">Thyroid cancer</z:e> was found in 5 patients (4.7%), <z:hpo ids='HP_0003002'>breast cancer</z:hpo> in 3 (2.8%), <z:hpo ids='HP_0003003'>colon cancer</z:hpo> in 2 (1.9%), <z:e sem="disease" ids="C0242379" disease_type="Neoplastic Process" abbrv="">lung cancer</z:e> in 2 (1.9%), <z:e sem="disease" ids="C0007847" disease_type="Neoplastic Process" abbrv="">cervix cancer</z:e> in 1 (0.9%), <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) in 1 (0.9%), <z:mpath ids='MPATH_354'>cholangiocarcinoma</z:mpath> in 1 (0.9%), and multiple <z:chebi fb="32" ids="24621">endocrine</z:chebi> <z:hpo ids='HP_0002664'>neoplasm</z:hpo> (MEN) type 1 in 1 patient (0.9%) </plain></SENT>
<SENT sid="5" pm="."><plain><z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">Cancer</z:e> was more common in the male patients (P = 0.046) and high levels of GH increased the risk of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> development (P = 0.046) </plain></SENT>
<SENT sid="6" pm="."><plain>In this series, the most commonly detected <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> types were thyroid followed by breast and <z:hpo ids='HP_0003003'>colon cancers</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain>Although high levels of initial GH seemed to increase the risk of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> development in acromegalic patients, age, gender, age at the time of diagnosis, duration of disease, and initial IGF-I levels were not associated with <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> development </plain></SENT>
</text></document>